BioResource International, Inc. Academic Research Partners to Present the
Effects of Xylanase and Protease Feed Enzymes in Swine Diets
at ASAS-CSAS 2017 Annual Meeting
Research Triangle Park, N.C. — June 21, 2017—BioResource International, Inc. (BRI), a global biotechnology company specializing in the research, development and manufacture of high-performance enzyme feed additives for optimizing animal nutrition and gut health, announced today that findings from two research studies using its xylanase feed additive Xylamax® and market-leading protease feed additive Versazyme® in swine diets will be presented at the American Society of Animal Science (ASAS) and Canadian Society of Animal Science (CSAS) 2017 Annual Meeting July 8 – 12, 2017, in Baltimore, Md.
The first study, “Effect of Supplemental Protease on Growth Performance, Nutrient Digestibility, and Gut Health in Nursery Pigs Fed Diets with Corn or Sorghum,” was conducted in collaboration with research partners from North Carolina State University’s Department of Animal Science, including Hongyu Chen, Inkyung Park, Shihai Zhang and Sung Woo Kim, Ph.D. Research findings will be presented on Monday, July 10, at 3:30 p.m. in the Baltimore Convention Center, room 317. Results from the 40-day trial found that fully replacing corn with sorghum in diets could be beneficial to nursery pigs in terms of enhanced feed intake and growth by potentially reducing oxidative stress. In addition, the study found that the supplementation of protease, such as BRI’s Versazyme feed additive, improved overall protein digestion and gut health, irrespective of sorghum- or corn-based diets.
A second research study, “Effects of Combinational Use of Xylanase and Protease on Growth Performance and Gut Health of Newly Weaned Pigs,” conducted in collaboration with North Carolina State University Animal Scientists Marcos Duarte, Inkyung Park, Wanpuech Parnsen and Sung Woo Kim, Ph.D. will be presented on Tuesday, July 11, at 3:30 p.m. in the Baltimore Convention Center, room 317. The 24-day study found that Xylamax, BRI’s xylanase product, reduced digesta viscosity and oxidative stress in newly weaned pigs and that protease improved feed efficiency. Additionally, results showed that the combinational use of xylanase and protease further enhanced growth performance and gut integrity.
“Utilizing our strong network of academic collaborators, we continue to expand our research program relative to enzyme effects on swine production,” explained JJ Wang, Ph.D., senior vice president and chief technology officer of BRI. “As the use of antibiotics continues to decline, it is promising to see that our enzyme technologies provide solutions that can improve gut health, optimize nutrition and further enhance overall performance in swine.”
For more information on the ASAS-CSAS 2017 Annual Meeting and the BRI presentation, please visit www.asas.org/meetings/annual-2017.
Founded in 1999, BRI is a global biotechnology company specializing in the research, development and manufacture of high-performance enzyme feed additives that help poultry and swine producers optimize animal nutrition and gut health. BRI products are effective tools for managing rising feed costs and feed ingredient quality variations in a way that is safe for animals, humans and the environment. The company has earned a reputation as a team of trusted enzyme experts who utilize their scientific expertise to create innovative products that solve nutritional and sustainability challenges facing meat producers around the world. For more information, please visit http://briworldwide.com/.
Public Relations, BRI